View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200, Esophageal Cancer
Protocol-ID: 2559 V1.0 (Mini), TISL200, Esophageal CaIndication(s)
- Esophageal Cancer (Squamous Cell Carcinoma); ICD-10 C15.-
Links
- Tislelizumab (tevimbra) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.03.2024